People with HIV in care smoke at twice the rate of the general population.
Dolutegravir vs. Raltegravir
A Phase III study compares the two integrase inhibitors.
Data presented at CROI show a child born with HIV and treated with ARVs has been "functionally cured."
Boehringer Ingelhiem's Phase III clinical trial shows 80 percent early success rate for HCV protease inhibitor faldaprevir.
Long-acting PrEP injection prevents
of simian HIV.
The Hep C Pipeline
Second-generation antiviral hep C therapies show high cure rates in people who previously failed therapy.
Questions remain after interventions fail to protect from HIV.
Lowering "Bad" Cholesterol
Studies show statin med Livalo is more effective at lowering LDL cholesterol in HIV-positive adults.
Sex and the City
Gay and bisexual men in urban areas are more aware of their HIV status but prevalence holds steady.
A small early trial shows Merck's NNRTI MK-1439 is safe and well tolerated.
Wrapping It Up
Using condoms consistently for anal sex prevents HIV transmission 70% of the time.
ARVs reduce cellular inflammation among elite controllers